KAREN MORIN LIMAYE: Open Payments
NPI 1912974627 · WAYNE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,108 in 90 payments from 18 companies in 2025. Trend: 2023 $1,636 · 2024 $2,470 · 2025 $2,108
Food & beverage: $2,008Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $827 |
| ABBVIE INC. | 20 | $253 |
| Galderma Laboratories, L.P. | 9 | $237 |
| UCB, Inc. | 8 | $176 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $146 |
| E.R. Squibb & Sons, L.L.C. | 5 | $106 |
| Organon LLC | 5 | $77 |
| Amgen Inc. | 4 | $66 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Janssen Scientific Affairs, LLC | 1 | $30 |
Products named: TREMFYA, NEMLUVIO, SKYRIZI, Bimzelx, ILUMYA, Sotyktu, OTEZLA, RINVOQ.
Industry payments across PA — which companies pay providers there.
